These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 34992419)
21. Elevated lymphocyte specific protein 1 expression is involved in the regulation of leukocyte migration and immunosuppressive microenvironment in glioblastoma. Cao JY; Guo Q; Guan GF; Zhu C; Zou CY; Zhang LY; Cheng W; Wang GL; Cheng P; Wu AH; Li GY Aging (Albany NY); 2020 Jan; 12(2):1656-1684. PubMed ID: 32003759 [TBL] [Abstract][Full Text] [Related]
22. A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma. Zhang C; Wang M; Ji F; Peng Y; Wang B; Zhao J; Wu J; Zhao H Biomed Res Int; 2021; 2021():8872977. PubMed ID: 33553434 [TBL] [Abstract][Full Text] [Related]
24. Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients. Guo Q; Guan GF; Cheng W; Zou CY; Zhu C; Cheng P; Wu AH CNS Neurosci Ther; 2019 Mar; 25(3):343-354. PubMed ID: 30311408 [TBL] [Abstract][Full Text] [Related]
25. Immunological classification of glioblastoma and its prognostic implications. Wang Q; Lin W; Liu T; Hu J; Zhu Y Am J Transl Res; 2022; 14(11):8009-8022. PubMed ID: 36505340 [TBL] [Abstract][Full Text] [Related]
26. RNA-seq for identification of therapeutically targetable determinants of immune activation in human glioblastoma. Bagley SJ; Hwang WT; Brem S; Linette GP; O'Rourke DM; Desai AS J Neurooncol; 2019 Jan; 141(1):95-102. PubMed ID: 30353265 [TBL] [Abstract][Full Text] [Related]
27. High Expression of Triggering Receptor Expressed on Myeloid Cells 1 Predicts Poor Prognosis in Glioblastoma. Ma K; Guo Q; Zhang X; Li Y Onco Targets Ther; 2023; 16():331-345. PubMed ID: 37274309 [TBL] [Abstract][Full Text] [Related]
28. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database. Lei CG; Jia XY; Sun WJ Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982 [TBL] [Abstract][Full Text] [Related]
29. Novel macrophage-related gene prognostic index for glioblastoma associated with M2 macrophages and T cell dysfunction. Ji H; Liu Z; Wang F; Sun H; Wang N; Liu Y; Hu S; You C Front Immunol; 2022; 13():941556. PubMed ID: 36177003 [TBL] [Abstract][Full Text] [Related]
31. A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction. Niu X; Sun J; Meng L; Fang T; Zhang T; Jiang J; Li H Front Oncol; 2020; 10():590352. PubMed ID: 33392085 [TBL] [Abstract][Full Text] [Related]
32. Dual role of ARPC1B in regulating the network between tumor-associated macrophages and tumor cells in glioblastoma. Liu T; Zhu C; Chen X; Wu J; Guan G; Zou C; Shen S; Chen L; Cheng P; Cheng W; Wu A Oncoimmunology; 2022; 11(1):2031499. PubMed ID: 35111386 [TBL] [Abstract][Full Text] [Related]
33. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment. Jia D; Li S; Li D; Xue H; Yang D; Liu Y Aging (Albany NY); 2018 Apr; 10(4):592-605. PubMed ID: 29676997 [TBL] [Abstract][Full Text] [Related]
34. Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis. Zhao B; Wang Y; Wang Y; Dai C; Wang Y; Ma W Front Immunol; 2021; 12():557994. PubMed ID: 34220791 [TBL] [Abstract][Full Text] [Related]
35. MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas. Wang QW; Sun LH; Zhang Y; Wang Z; Zhao Z; Wang ZL; Wang KY; Li GZ; Xu JB; Ren CY; Ma WP; Wang HJ; Li SW; Zhu YJ; Jiang T; Bao ZS J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34667077 [TBL] [Abstract][Full Text] [Related]
36. Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures. Xiong Y; Xiong Z; Cao H; Li C; Wanggou S; Li X Cancer Cell Int; 2020; 20():37. PubMed ID: 32021566 [TBL] [Abstract][Full Text] [Related]
37. HK3 stimulates immune cell infiltration to promote glioma deterioration. Li S; Li Z; Wang X; Zhong J; Yu D; Chen H; Ma W; Liu L; Ye M; Shen R; Jiang C; Meng X; Cai J Cancer Cell Int; 2023 Oct; 23(1):227. PubMed ID: 37779195 [TBL] [Abstract][Full Text] [Related]
38. Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development. Lin H; Wang K; Xiong Y; Zhou L; Yang Y; Chen S; Xu P; Zhou Y; Mao R; Lv G; Wang P; Zhou D Front Immunol; 2022; 13():773264. PubMed ID: 35185876 [TBL] [Abstract][Full Text] [Related]
39. Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses. Liu YQ; Wu F; Li JJ; Li YF; Liu X; Wang Z; Chai RC Front Oncol; 2019; 9():1433. PubMed ID: 31921684 [No Abstract] [Full Text] [Related]
40. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas. Zhao WJ; Ou GY; Lin WW Front Immunol; 2021; 12():682415. PubMed ID: 34054873 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]